Hlf is a genetic modifier of epilepsy caused by voltage-gated sodium channel mutations.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Epilepsy Research

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.eplepsyres.2015.11.016PMID 26656780PMCID PMC4698075
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Antiepileptic activity of preferential inhibitors of persistent sodium current

  2014cited by this paper
• Strain- and age-dependent hippocampal neuron sodium currents correlate with epilepsy severity in Dravet syndrome mice.

  2014cited by this paper
• Mapping genetic modifiers of survival in a mouse model of Dravet syndrome

  2014cited by this paper
• Sudden unexpected death in a mouse model of Dravet syndrome.

  2013cited by this paper
• Confirmation of an epilepsy modifier locus on mouse chromosome 11 and candidate gene analysis by RNA‐Seq

  2012cited by this paper
• Neuronal voltage-gated ion channels are genetic modifiers of generalized epilepsy with febrile seizures plus.

  2011cited by this paper
• Voltage-gated potassium channel KCNV2 (Kv8.2) contributes to epilepsy susceptibility

  2011cited by this paper
• Sodium channel gene family: epilepsy mutations, gene interactions and modifier effects

  2010cited by this paper
• Vitamin B6 dependent seizures.

  2009cited by this paper
• Fine mapping of an epilepsy modifier gene on mouse Chromosome 19

  2009cited by this paper
• Reduced sodium current in GABAergic interneurons in a mouse model of severe myoclonic epilepsy in infancy

  2006cited by this paper
• Genetic modifiers affecting severity of epilepsy caused by mutation of sodium channelScn2a

  2005cited by this paper
• The loss of circadian PAR bZip transcription factors results in epilepsy.

  2004influential reference
• A gain-of-function mutation in the sodium channel gene Scn2a results in seizures and behavioral abnormalities.

  2001cited by this paper
• Pyridoxal phosphate-dependent enzymes.

  1995cited by this paper
• Vitamin B6‐dependent seizures

  1978cited by this paper

• Behavioral and epileptic phenotypes in a CHD2-related developmental delay model.

  2025cites this paper
• Deciphering SCN2A: A comprehensive review of rodent models of Scn2a dysfunction

  2025cites this paper
• Spotlight on mechanism of sudden unexpected death in epilepsy in Dravet syndrome

  2025cites this paper
• Exploring the Genotype–Phenotype Correlations in a Child with Inherited Seizure and Thrombocytopenia by Digenic Network Analysis

  2024cites this paper
• Deciphering SCN2A: A comprehensive review of rodent models of Scn2a dysfunction

  2024cites this paper
• Heat-induced seizures, premature mortality, and hyperactivity in a novel Scn1a nonsense model for Dravet syndrome

  2023cites this paper
• Axonopathy and altered synaptic development in early hippocampal epileptogenesis of Dravet syndrome

  2023cites this paper
• A novel SCN8A variant of unknown significance in pediatric epilepsy: a case report

  2023cites this paper
• Strain-dependent effects on neurobehavioral and seizure phenotypes in Scn2aK1422E mice

  2023cites this paper
• Heterozygous deletion of Gpr55 does not affect a hyperthermia-induced seizure, spontaneous seizures or survival in the Scn1a+/- mouse model of Dravet syndrome

  2023cites this paper
• Phenotypic and Genotypic Characteristics of SCN1A Associated Seizure Diseases

  2022cites this paper
• SCN2A and Its Related Epileptic Phenotypes

  2021cites this paper
• Interneuron Dysfunction in a New Mouse Model of SCN1A GEFS+

  2021cites this paper
• The K328M substitution in the human GABAA receptor gamma2 subunit causes GEFS+ and premature sudden death in knock-in mice

  2021cites this paper
• The Heat Sensing Trpv1 Receptor Is Not a Viable Anticonvulsant Drug Target in the Scn1a +/− Mouse Model of Dravet Syndrome

  2021cites this paper
• The endocannabinoid system impacts seizures in a mouse model of Dravet syndrome.

  2021cites this paper
• A transcriptional constraint mechanism limits the homeostatic response to activity deprivation in mammalian neocortex

  2021cites this paper
• Developmentally regulated impairment of parvalbumin interneuron synaptic transmission in an experimental model of Dravet syndrome

  2021cites this paper
• Effects of SCN1A and SCN2A polymorphisms on responsiveness to valproic acid monotherapy in epileptic children

  2021cites this paper
• Gabra2 is a genetic modifier of Dravet syndrome in mice

  2020cites this paper
• Modifier genes in SCN1A‐related epilepsy syndromes

  2020cites this paper
• Aberrant expression of PAR bZIP transcription factors is associated with epileptogenesis, focus on hepatic leukemia factor

  2020cites this paper
• SCN2A channelopathies in the autism spectrum of neuropsychiatric disorders: a role for pluripotent stem cells?

  2020cites this paper
• Precision medicine and therapies of the future

  2020cites this paper
• Predicting the impact of sequence motifs on gene regulation using single-cell data

  2020cites this paper
• Cortical RORβ is required for layer 4 transcriptional identity and barrel integrity

  2019cites this paper
• Interneuron dysfunction in a new knock-in mouse model of SCN1A GEFS+

  2019cites this paper
• Augmented Reticular Thalamic Bursting and Seizures in Scn1a-Dravet Syndrome

  2019cites this paper
• Gene expression profiling in a mouse model of Dravet syndrome

  2019influential citation
• The Role of Hepatic Leukemia Factor in Hematopoiesis

  2018cites this paper
• Genetic and phenotypic heterogeneity suggest therapeutic implications in SCN 2 A-related disorders

  2018cites this paper
• C57BL/6J and C57BL/6N substrains differentially influence phenotype severity in the Scn1a +/− mouse model of Dravet syndrome

  2018cites this paper
• Potentiating α2 subunit containing perisomatic GABAA receptors protects against seizures in a mouse model of Dravet Syndrome

  2018cites this paper
• FOXD3 inhibits SCN2A gene transcription in intractable epilepsy cell models

  2018cites this paper
• Integration of biological/pathophysiological contexts to help clarify genotype‐phenotype mismatches in monogenetic diseases. Childhood epilepsies associated with SCN2A as a case study

  2018cites this paper
• Genetics update: Monogenetics, polygene disorders and the quest for modifying genes

  2017cites this paper
• Dravet and GEFS+ Syndromes

  2017cites this paper
• Genetic and phenotypic heterogeneity suggest therapeutic implications in SCN2A-related disorders

  2017cites this paper
• Cacna1g is a genetic modifier of epilepsy in a mouse model of Dravet syndrome

  2017cites this paper
• WITHDRAWN: Genetics update: Monogenetics, polygene disorders and the quest for modifying genes.

  2017cites this paper
• CaMKII modulates sodium current in neurons from epileptic Scn2a mutant mice

  2017cites this paper
• Rare variants of small effect size in neuronal excitability genes influence clinical outcome in Japanese cases of SCN1A truncation-positive Dravet syndrome

  2017cites this paper
• Cacna1g is a genetic modifier of epilepsy caused by mutation of voltage‐gated sodium channel Scn2a

  2016cites this paper